Brauckhoff M, Kamprad M, Steuber J
Klinik für Allgemeinchirurgie, Martin-Luther-Universität Halle-Wittenberg.
Med Klin (Munich). 2001 Sep 15;96(9):545-9. doi: 10.1007/pl00002239.
We report the case of a 51-year-old woman who suffered from breast cancer and developed meningeal carcinomatosis of the brain stem with deafness and blindness. Radiotherapy was given but led to remarkable deterioration of the condition and strong headache. We performed intrathecal therapy with methotrexate (MTX) via lumbar application. Under this regimen, the patient immediately showed complete improvement of the headache and a partial recovery of hearing. There were no side effects apart from alopecia. MTX concentrations in liquor and blood were remarkably inconsistent. 4 weeks after MTX therapy, MRT revealed partial remission of the meningiosis of the brain stem but progression on both hemispheres. 5 weeks after the beginning of the intrathecal therapy, the patient died.
Despite pharmacokinetic problems we consider lumbar intrathecal therapy with MTX a suitable procedure for patients with leptomeningeal carcinomatosis and poor performance status.
我们报告了一例51岁女性乳腺癌患者,该患者发生脑干脑膜癌病,出现耳聋和失明。给予放疗,但导致病情显著恶化并出现剧烈头痛。我们通过腰椎穿刺进行甲氨蝶呤(MTX)鞘内治疗。在此治疗方案下,患者头痛立即完全缓解,听力部分恢复。除脱发外无其他副作用。脑脊液和血液中的MTX浓度明显不一致。MTX治疗4周后,磁共振成像(MRT)显示脑干脑膜炎部分缓解,但双侧半球病情进展。鞘内治疗开始5周后,患者死亡。
尽管存在药代动力学问题,但我们认为对于软脑膜癌病且身体状况较差的患者,腰椎鞘内注射MTX治疗是一种合适的方法。